Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults (APPLAUD)

An International Phase II, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of LAU-7b administered once-daily for 6 months for the treatment of CF.

Learn more at ClinicalTrials.gov NCT03265288